Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medication Development for Protracted Abstinence in Alcoholism: Suvorexant Versus Placebo

NCT04229095 is registered in ClinicalTrials.gov with The Scripps Research Institute as lead sponsor.

NCT NCT04229095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04229095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medication Development for Protracted Abstinence in Alcoholism: Suvorexant Versus Placebo
Lead sponsor
The Scripps Research Institute
Phase
Phase 2
Overall status
Completed
Start date
November 17, 2021
Completion date
November 8, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)